Member

This kind of self-restraint is common and ordinary in other industries where there is a public health concern about noxious chemicals. In the chemical industry there is the Responsible Care initiative, and I urge the Bill team to have a look at it. It is a voluntary restraint by the chemical industry, whose products are important for our sustenance but present a public health risk. In it, there is a public audit, the objective of building public trust and a recognition that the sale of these chemicals has an environmental and public health consequence. I applaud the chemical industry for this self-restraint and I ask the tobacco industry to show the same kinds of behaviour. Likewise, the pharmaceutical industry, with which I am more familiar, also has self-restraining ordinances—for instance, on the marketing and packaging of its pharmaceuticals.